Showing 781 - 800 results of 1,775 for search '"Therapy"', query time: 0.07s Refine Results
  1. 781

    Efficacy of Kolofort in Combined Functional Gastroenterological Pathology: an Open Study by Yu. P. Uspenskiy, O. S. Mirzoev, Yu. A. Fominykh, A. A. Gnutov, S. V. Polyushkin

    Published 2020-12-01
    “…All patients received Kolofort 2 times a day, 2 tablets per dose for 28 days.Results. The Kolofort therapy improved the clinical symptoms according to the “7x7” questionnaire; the primary mean total score was 17.7 ± 3.6, decreased to 10.3 ± 2.5 past 14 days (p < 0.0001) and to 7.6 ± 1.5 - past 28 days of therapy (p < 0.0001). …”
    Get full text
    Article
  2. 782

    Disparities in Opioid Use Disorder Treatment Admissions in the United States by Peter J. Mallow, Michael Mercado, Michael Topmiller

    Published 2020-06-01
    “…The fully saturated regression results found that the odds of Cincinnati individuals receiving planned medication-assisted therapy were 0.497 (95% CI, 0.451–0.546; P value < 0.001). …”
    Get full text
    Article
  3. 783

    Surgical Treatment Patterns, Healthcare Resource Utilization, and Economic Burden in Patients with Tenosynovial Giant Cell Tumor Who Underwent Joint Surgery in the United States by Feng Lin, Winghan J. Kwong, Sherry Shi, Irina Pivneva, Eric Q. Wu, John A. Abraham

    Published 2022-03-01
    “…Opioids and nonsteroidal anti-inflammatory drugs (NSAIDs), and physical therapy, occupational therapy, and rehabilitation services, were commonly used during baseline (45%, 40%, and 30%, respectively). …”
    Get full text
    Article
  4. 784

    Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis by Yu. P. Uspenskiy, S. V. Ivanov, Yu. A. Fominykh

    Published 2022-03-01
    “…The 5-ASA therapy remains the mainstay UC treatment in routine outpatient practice, with prescription rate of 80–90%. …”
    Get full text
    Article
  5. 785

    Rimegepant for the treatment of migraine by Amnon A. Berger, Ariel Winnick, Austin H. Carroll, Alexandra Welschmeyer, Nathan Li, Marc Colon, Antonella Paladini, Giovanni F. Ramírez, Jamal Hasoon, Elyse M. Cornett, Jaehong Song, Giustino Varrassi, Adam M. Kaye, Alan D. Kaye, Latha Ganti

    Published 2022-10-01
    “…Prophylactic therapy may reduce the occurrence of acute migraine attacks in selected patients, but does not completely eliminate it. …”
    Get full text
    Article
  6. 786

    Selecting the Best Music for the Moment in a Music and Imagery Session by Petra Jerling, Carmen Angulo Sánchez-Prieto, Isabel Solana Rubio

    Published 2024-03-01
    “…In receptive music therapy, clients listen to music for therapeutic purposes. …”
    Get full text
    Article
  7. 787

    Clostridium difficile-associated disease in versatile hospital patient population and risk factors for its development by Ya. N. Yarushina, G. B. Kolotova, V. A. Rudnov, V. A. Bagin

    Published 2018-08-01
    “…Retrospective analysis of 131 case records of the in-patients of Yekaterinburg City Hospital No. 40 for the year 2014 who developed diarrhea during antibacterial therapy was carried out. According to fecal filtrate test for Clostridium difficile (CD), patients were divided into two groups: 71 patients had positive test, 60 - negative. …”
    Get full text
    Article
  8. 788

    The Role of Duodenogastroesophageal Reflux in the Progression of Gastroesophageal Reflux Disease: From Esophagitis to Adenocarcinoma by O. A. Storonova, A. V. Paraskevova, A. A. Makushina

    Published 2024-08-01
    “…The addition of UDCA drugs to the basic therapy is pathogenetically justified in patients with GERD in the presence of duodenogastroesophageal reflux. …”
    Get full text
    Article
  9. 789

    Helicobacter pylori infection diagnostics and choice of eradication treatment: results of inquiry of doctors from different regions of Russian Federation by N. N. Dekhnich, R. S. Kozlov, O. A. Sablin, Ye. A. Prischepova

    Published 2018-08-01
    “…At the choice of second line antihelicobacter therapy mode components 34.8% of doctors complied to RGA guidelines. …”
    Get full text
    Article
  10. 790
  11. 791

    Case Report: Combined Autoimmune Pancreatitis, Ulcerative Colitis and Sclerosing Cholangitis in 28-y.o. Patient by A. R. Khurmatullina, A. V. Okhlobystin, L. N. Androsova, R. T. Rzayev, A. S. Tertychnyy, A. P. Kiryukhin, O. Z. Okhlobystina, M. S. Zharkova, O. S. Shifrin, V. T. Ivashkin

    Published 2025-02-01
    “…The patient was recommended to receive biologic therapy for UC remission induction.Conclusion. Differential diagnostics of combined autoimmune lesions of the liver, the pancreas and colon may be complicated and carried out ex juvantibus according to response to immunosuppressive therapy.…”
    Get full text
    Article
  12. 792

    Telaprevir: options of application in separate patient groups by M. V. Mayevskaya, I. N. Tikhonov, V. T. Ivashkin

    Published 2013-10-01
    “…To discuss potential of telaprevir application in patients with the 1-st genotype of chronic hepatitis C (CHC) representing certain difficulties in treatment, in patients having antiviral therapy experience, patients with liver cirrhosis, including, those, enrolled to liver transplantation waiting list, and after liver transplantation, in patients with human immunodeficiency virus coinfection, as well as nephrologic patients receiving renal substitution therapy.Key points. …”
    Get full text
    Article
  13. 793

    Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease by Adrian Peacock, Frances C. Dehle, Oscar A. Mesa Zapata, Francesca Gennari, Maro R.I. Williams, Nada Hamad, Stephen Larsen, Simon J. Harrison, Colman Taylor

    Published 2024-02-01
    “…**Background:** The mainstay first-line therapy for chronic graft-vs-host disease (cGVHD) is corticosteroids; however, for steroid-refractory patients, there is a distinct lack of cost-effective or efficacious treatment. …”
    Get full text
    Article
  14. 794

    Wanneer jongmense hoop verloor: 'n pastorale perspektief op die selfmoordkontemplerende adolessent by A. R. Brunsdon, J. Janse van Rensburg

    Published 2003-12-01
    “…A covenant-driven pastoral approach could serve as an example of the contribution which pastoral therapy could make towards combating this destructive phenomenon. …”
    Get full text
    Article
  15. 795

    'n Narratiewe pastorale terapie met depressiewe persone by JD Crafford, DJ Kotzé

    Published 1997-06-01
    “…Two case studies exemplify this way of doing pastoral therapy with people experiencing depression. …”
    Get full text
    Article
  16. 796

    Increase in methemoglobin fraction due to the use of glyceryl trinitrate patches in preterm infants: a case report and literature review by Andrea Calandrino, Andrea Calandrino, Francesco Vinci, Francesco Vinci, Marcella Battaglini, Marcella Battaglini, Samuele Caruggi, Samuele Caruggi, Chiara Andreato, Chiara Andreato, Carolina Montobbio, Marianna Vannati, Diego Minghetti, Giorgia Brigati, Luca Antonio Ramenghi, Luca Antonio Ramenghi

    Published 2025-02-01
    “…MeHb levels normalized after 18 h, and after adjusting therapy, ischemia resolved successfully.DiscussionWe report the case of a premature IUGR infant who developed elevated methaemoglobin (MeHb) levels during topical GTN therapy for catheter-related extremity ischemia. …”
    Get full text
    Article
  17. 797

    Clinical significance of Helicobacter pylori infection in iron-deficiency anemia: features of comprehensive treatment approach by I. V. Mayev, S. A. Kochetov

    Published 2016-08-01
    “…Subgroup 1b patients received only iron supplementation therapy. The group of comparison included 50 H. pylori-positive patients without coexistent iron deficiency who received the first line eradication therapy for 10 days as well. …”
    Get full text
    Article
  18. 798

    Pegilated interferon α2а in treatment of chronic hepatitis C by P. O. Bogomolov, S. V. Koblov, A. O. Buyeverov, M. V. Matsiyevich, O. S. Kuzmina, N. A. Barsukova, N. V. Dubinina

    Published 2012-09-01
    “…To analyze experience of pegIFN-α 2а (Pegasys®) application at combined antiviral therapy of chronic hepatitis C (CHC) within the framework of the Moscow regional regional program on viral hepatites treatment.Material and methods. …”
    Get full text
    Article
  19. 799

    Risk Factors and Prevention of Upper Gastrointestinal Complications Associated with Nonsteroidal Anti-Inflammatory Drugs by N. V. Bakulina, S. V. Tikhonov, K. A. Nagornova

    Published 2025-02-01
    “…All patients who are going to receive NSAIDs should be diagnosed with H. pylori and treated with eradication therapy if this infection is detected. Even in patients without risk factors for gastrointestinal complications and with short courses of therapy, coxibs or a combination of NSAIDs and proton pump inhibitors may be considered. …”
    Get full text
    Article
  20. 800

    Spastic Paraparesis in Young Men With Spinal Meningioma and Spinal Arteriovenous Malformation: A Case Report by Leonard Christianto Singjie, Ivan Jeremia, Esdras Ardi Pramudita

    Published 2021-09-01
    “…Laminectomy and tumor destruction were the gold standards of therapy, and the symptom was relieved. Conclusion: A complete examination is the main key in determining the appropriate therapy for the patient's disease. …”
    Get full text
    Article